conray 30
Pharmaranks rates Conray 30 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Conray 30 (Iothalamate Meglumine) is a medication supplied as an injectable.
Iothalamate Meglumine · by Liebel-Flarsheim
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Iothalamate Meglumine
- Form
- Injectable
- Strength
- Iothalamate Meglumine 30%
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Liebel-Flarsheim
- FDA application
- NDA016983
- Availability
- Discontinued (per FDA)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Conray 30 rated?
- pharmaranks gives Conray 30 a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Conray 30?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Conray 30. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Conray 30?
- Conray 30 is marketed by Liebel-Flarsheim. You can see Liebel-Flarsheim's full profile, rating, and other products on pharmaranks.
- Is Conray 30 a brand-name or generic drug?
- Conray 30 is a brand-name product with the active ingredient Iothalamate Meglumine.
- Is Conray 30 available over the counter?
- No. Conray 30 is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Conray 30 come in?
- Conray 30 is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Conray 30 FDA-registered?
- Conray 30 is on record with the U.S. FDA under application number NDA016983. You can verify this on its official FDA label.
- Has Conray 30 been recalled by the FDA?
- Conray 30 has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Conray 30 safe?
- There's no single safe-or-not verdict. pharmaranks gives Conray 30 a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about IOTHALAMATE MEGLUMINE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 4 reports naming IOTHALAMATE MEGLUMINE — the active ingredient in Conray 30, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- agranulocytosis1 reports
- anaphylactic reaction1 reports
- angioedema1 reports
- cough1 reports
- fixed eruption1 reports
- neoplasm progression1 reports
- pyrexia1 reports
- vomiting1 reports
Read these as a signal, not a rate. A report does not mean IOTHALAMATE MEGLUMINE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
benzamycin
Benzoyl Peroxide and Erythromycin
colazal
Balsalazide Disodium
cuprimine
Penicillamine
mysoline
Primidone
retin-a
Tretinoin
tolak
Fluorouracil
Compare Conray 30 head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
conray 30
70/100